Incidence and risk factors for nosocomial infections caused by fluoroquinolone-resistant Escherichia coli

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 8, 2003, Pages 492-495

  Huotari, K ^a   Tarkka, E ^b   Valtonen, V ^c   Kolho, E ^c  

^a Aurora Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Meilahti Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFALOTIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; URINARY TRACT DISEASE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FINLAND; FLUOROQUINOLONES; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 0041909719     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0975-6     Document Type: Article

References (15)

1. Ena J, Lopez-Perezagua MM, Martinez-Peinado C, Cia-Barrio MA, Ruiz-Lopez I (1998) Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis 30:103-107
2. Pena C, Albareda JM, Pallares R, Pujol M, Tubau F, Ariza J (1995) Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 39:520-524
3. Kahlmeter G (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS project. J Antimicrob Chemother 51:69-76
4. Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, Llovet T, Ruiz-Bremon A (1999) Emergence and dissemination of fluoroquinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 43:2736-2741
5. Cheong H, Yoo C, Sohn J, Kim W, Kim M, Park S (2001) Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis 33:48-53
6. Ena J, Amador C, Martinez C, Ortiz de la Tabla V (1995) Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 153:117-120
7. Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL (2002) Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162:2469-2477
8. McDonald LC, Chen F-J, Lo H-J, Yin H-J, Lu P-L, Huang C-H, Chen P, Lauderdale T-L, Ho M (2001) Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 45:3084-3091
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140
10. National Committee for Clinical Microbiology Standards (1997) Performance standards for antimicrobial disk suspectibility tests. Approved standard M2-A6. NCCLS, Villanova PA
11. Aparicio JR, Such J, Pascual S, et al. (1999) Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 31:277-283
12. Horcajada JP, Vila J, Moreno-Martinez A, et al (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55-59
13. Vila J, Simon K, Ruiz J, et al. (2002) Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 186:1039-1042
14. Harris AD, Samore MH, Lipsitch M, et al. (2002) Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci and Escherichia coli. Clin Infect Dis 34:1558-1563
15. Lee Y-E, Cesario T, McCauley V, et al. (1998) Low-level colonization and infection with ciprofloxacin-resistant gram-negative bacilli in a skilled nursing facility. Am J Infect Control 26:552-557